Toward Peptide-Based Inhibitors as Therapies for Parkinson's Disease

Future Medicinal Chemistry - United Kingdom
doi 10.4155/fmc.15.139
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Science Ltd

Related search

Proceedings: Moving Toward Cell-Based Therapies for Heart Disease

Stem cells translational medicine
MedicineDevelopmental BiologyCell Biology
2015English

Rational Drug Design of Peptide-Based Therapies for Sickle Cell Disease

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2019English

Long-Term Outcomes of Surgical Therapies for Parkinson's Disease

Movement Disorders
Neurology
2012English

Blood-Based Biomarkers for Parkinson's Disease

Parkinsonism and Related Disorders
GerontologyGeriatricsNeurology
2014English

Cell-Based Therapies for Huntington's Disease

Drug Discovery Today
Drug DiscoveryPharmacology
2014English

The History of Parkinson's Disease: Early Clinical Descriptions and Neurological Therapies

Cold Spring Harbor perspectives in medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

Mesenchymal Stem Cell Based Therapy for Parkinson's Disease

International Journal of Stem Cell Research & Therapy
2019English

Platinum-Based Inhibitors of Amyloid- As Therapeutic Agents for Alzheimer's Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Cytokine Modulators as Novel Therapies for Airway Disease

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy